Autor: Wade, David - Prolib Integro

Skocz do pozycji: 1.

Tytuł:: Hematological and antifungal properties of temporin A and a cecropin A-temporin A hybrid.
Autorzy:: Wade, David
Silveira, Angela
Rollins-Smith, Louis
Bergman, Tomas
Silberring, Jerzy
Lankinen, Hilkka
Tematy:: cecropin A-temporin A hybrid
coagulation
temporin A
antifungal
hemolysis; Pokaż więcej
Wydawca:: Polskie Towarzystwo Biochemiczne
Powiązania:: https://bibliotekanauki.pl/articles/1044081.pdf Link otwiera się w nowym oknie
Opis:: Temporin A (TA) and a cecropin A-temporin A hybrid peptide (CATA) were synthesized and assayed for their hemolytic, anticoagulant, and antifungal properties. CATA retains significant antifungal activity, is less hemolytic than TA, and inhibits blood coagulation. These results recommend further studies of the biological activities of CATA.
Dostawca treści:: Biblioteka Nauki

Artykuł

na półce

Skocz do pozycji: 2.

Tytuł:: Activities of temporin family peptides against the chytrid fungus (Batrachochytrium dendrobatidis) associated with global amphibian declines
Autorzy:: Rollins-Smith, Louise A.
Bergman, Tomas
Silberring, Jerzy
Reinert, Laura K.
Conlon, J. Michael
Lankinen, Hilkka
Doersam, Jennifer K.
Wade, David
Carey, Cynthia
Dostawca treści:: Repozytorium Uniwersytetu Jagiellońskiego

Artykuł

na półce

Skocz do pozycji: 3.

Tytuł:: ROBUST : A Phase III Study of Lenalidomide Plus R-CHOP Versus Placebo Plus R-CHOP in Previously Untreated Patients With ABC-Type Diffuse Large B-Cell Lymphoma
Autorzy:: Yamamoto, Kazuhito
Mocikova, Heidi
Kato, Koji
Vitolo, Umberto
Scott, David W.
Yoon, Dok Hyun
Hudak, Krista
Izutsu, Koji
Piazza, Francesco
Nowakowski, Grzegorz S.
Molinari, Anna Lia
Jurczak, Wojciech
Kilcoyne, Adrian
Chiappella, Annalisa
Cavallo, Federica
Hersey, Sarah
Zhu, Jun
Russo, Jacqueline
Witzig, Thomas E.
Hong, Xiaonan
Belada, David
Jin, Jie
Ozcan, Muhit
Zhang, Qingyuan
Czuczman, Myron
Zhang, Jingshan
Tani, Monica
Gascoyne, Randy D.
Wade, Steve
Bergua, Juan Miguel
Opis:: PURPOSE Patients with the activated B-cell-like (ABC) subtype of diffuse large B-cell lymphoma (DLBCL) historically showed inferior survival with standard rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone (R-CHOP). Phase II studies demonstrated that adding the immunomodulatory agent lenalidomide to R-CHOP improved outcomes in ABC-type DLBCL. The goal of the global, phase III ROBUST study was to compare lenalidomide plus R-CHOP (R2-CHOP) with placebo/R-CHOP in previously untreated, ABC-type DLBCL. METHODS Histology and cell-of-origin type were prospectively analyzed by central pathology prior to random assignment and study treatment. Patients with ABC-DLBCL received lenalidomide oral 15 mg/d, days 1-14/21 plus standard R-CHOP21 versus placebo/R-CHOP21 for six cycles. The primary end point was progression-free survival (PFS) per independent central radiology review. RESULTS A total of 570 patients with ABC-DLBCL (n 5 285 per arm) were stratified by International Prognostic Index score, age, and bulky disease, and randomly assigned to R2-CHOP or placebo/R-CHOP. Baseline demographics were similar between arms. Most patients completed six cycles of treatment: 74% R2-CHOP and 84% placebo/R-CHOP. The most common grade 3/4 adverse events for R2-CHOP versus placebo/R-CHOP were neutropenia (60% v 48%), anemia (22% v 14%), thrombocytopenia (17% v 11%), and leukopenia (14% v 15%). The primary end point of PFS was not met, with a hazard ratio of 0.85 (95% CI, 0.63 to 1.14) and P5.29; median PFS has not been reached for either arm. PFS trends favoring R2-CHOP over placebo/R-CHOP were seen in patients with higher-risk disease. CONCLUSION ROBUST is the first DLBCL phase III study to integrate biomarker-driven identification of eligible ABC patients. Although the ROBUST trial did not meet the primary end point of PFS in all patients, the safety profile of R2-CHOP was consistent with individual treatments with no new safety signals.
Dostawca treści:: Repozytorium Uniwersytetu Jagiellońskiego

Artykuł

na półce

Skocz do pozycji: 4.

Tytuł:: Travel burden and clinical presentation of retinoblastoma : analysis of 1024 patients from 43 African countries and 518 patients from 40 European countries
Autorzy:: Klett, Artur
Ribadu, Dahiru
Muma, Kangwa I.
Msukwa, Gerald
Berete, Rokia C.
Schoeman, Judy
Csóka, Monika
Alsawidi, Khalifa M.
Lukamba, Robert M.
Nkanga, Elizabeth D.
van Hoefen Wijsard, Milo
Aghaji, Ada E.
Hadjistilianou, Theodora
Kalinaki, Abubakar
Khotenashvili, Zaza
Muyen, Okwen M.
Tyau-Tyau, Harba
Mengesha, Aemero A.
Elgalaly, Dina
Scanlan, Trish A.
Sherief, Sadik T.
Da Gama, Isac V.
Du Bruyn, Magritha
Mustak, Hamzah
Wackernagel, Werner
Zein, Ekhtelbenina
Balwierz, Walentyna
Essuman, Vera A.
Benmiloud, Sarra
Kemile, Pavlin Kroumov
Reynders, David
El Kettani, Asmaa
Obono-Obiang, Ghislaine
Matua, Marchelo
Sorochynska, Tetyana
Abdullahi, Shehu U.
Pawińska-Wąsikowska, Katarzyna
Chiwanga, Faraja S.
Ademola-Popoola, Dupe S.
Ali, Amany M.
Mndeme, Furahini G.
Ushakova, Tatiana L.
Naumenko, Larisa
Barranco, Honorio
Sharabi, Shirley
Ali Elhassan, Moawia M.
Renner, Lorna A.
Moreira, Claude
Riheia, Mussagy M.
Midena, Edoardo
Bowman, Richard
Cassoux, Nathalie
Kyara, Alice
Hederova, Stanislava
Popovic, Maja Beck
Svojgr, Karel
Waddell, Keith
Boubacar, Sahadatou Adamou
Matende, Ibrahim O.
Wime, Amelia D.C.
Lecuona, Karin
Kranjc, Branka Stirn
Tateshi, Bekim
Almeida, Argentino A.
Kosh Komba Palet, Jess Elio
Stones, David K.
Painter, Sally L.
Geel, Jennifer A.
Alfa Bio, Amadou I.
Lumbroso, Livia
De Potter, Patrick
Tandili, Alketa
Portabella, Silvia Alarcón
Bornfeld, Norbert
Amani Kabesha, Theophile B.
Nyaywa, Mutale
Cheikh, Sidi Sidi
Kivelä, Tero T.
Makan, Mayuri
Veleva-Krasteva, Nevyana V.
Manda, Chatonda
Chantada, Guillermo L.
Dod, Charlotte Wolley
Keren-Froim, Naama
Sylla, Fatoumata
Perić, Sanja
Jenkinson, Helen
Adio, Adedayo
Ziko, Othman A.O.
Oscar, Alexander Hugo
Said, Azza M.A.
Ssali, Grace
Parulekar, Manoj
Ritter-Sovinz, Petra
Aldana, David García
Bascaran, Covadonga
Dragomir, Monica D.
Pompe, Manca T.
Silva, Sónia
Elbahi, Amal M.
Valeina, Sandra
Wade, Patricia D.
Papyan, Ruzanna
Latinović, Slobodanka
Begue, Nieves Martín
Antonino, Romanzo
Kabore, Rolande L.
Zondervan, Marcia
Bouda, Gabrielle C.
Ndoye Roth, Paule Aida
Saakyan, Svetlana
Davidson, Alan
Lachmann, Eva S.
Gregersen, Pernille A.
Zhilyaeva, Katsiaryna
Desjardins, Laurence
Philbert, Remezo
Naidu, Gita
Theophile, Tuyisabe
Yarovaya, Vera A.
Boehme, Marianna
Alia, Donjeta B.
Guebessi, Nissrine Bennani
Mohamedani, Ahmed A.
Ida, Russo
Osei-Bonsu, Peter
All-Eriksson, Charlotta
Paiva, Luisa
Pochop, Pavel
Seregard, Stefan
Chernodrinska, Violeta S.
Pons, Jonathan J.
Krivaitiene, Dalia
Viksnins, Maris
Bouguila, Hédi
Wali Nigeria, Amina H.
Correa Llano, Maria G.
Paintsil, Vivian
Mayet, Ismail
Msina, Mchikirwa S.
Parrozzani, Raffaele
Umar, Ali B.
Elhaddad, Alaa M.
Munier, Francis L.
Guedenon, Koffi M.
Hordofa, Diriba F.
Ilic, Vesna R.
Boumedane, Amaria
Mbumba, Freddy B.
Reddy, M. Ashwin
Raobela, Léa
Capra l, Michael
Oguego, Ngozi C.
Balaguer, Julia
Bobrova, Nadia
Kardava, Tamar
Didi Fabian, Ido
Castela, Guilherme
Hummlen, Marlies
Blum, Sharon
Murgoi, Gabriela
Al Harby, Lamis
Gandiwa, Moira
Gizachew, Zelalem
Gomel, Nir
Lysytsia, Lesia
Tamamyan, Gevorg
Traoré, Fousseyni
Fernández-Teijeiro, Ana
Hassan, Sadiq
Foster, Allen
Kruger, Mariana
Biewald, Eva M.
Nikitovic, Marina
Stathopoulos, hristina
Kepak, Tomas
Husakova, Kristina
Elzembely, Mahmoud M.
Hessissen, Laila
Fasina, Oluyemi
Moll, Annette C.
Abdallah, Elhassan
Maka, Erika
Catala-Mora, Jaum
Evina, Ted Grimbert A.
Polyakov, Vladimir G.
Stacey, Andrew W.
Musa, Kareem O.
Yarovoy, Andrey A.
Urbak, Steen F.
Neroe, Vladimir
Sagoo, Mandeep S.
Astbury, Nicholas J.
Atsiaya, Rose
Yanga, Jenny M.
Biddulph, Shelley J.
Olechowski, Andrzej
San Román Pacheco, Sonsoles
Comsa, Codruta
Brichard, Bénédicte G.
Nkumbe, Henry
Cieslik, Krzysztof
Kapelushnik, Noa
Dostawca treści:: Repozytorium Uniwersytetu Jagiellońskiego

Artykuł

na półce

Informacja

Wyszukujesz frazę "Wade, David" wg kryterium: Autor